Clinisciences > PAX2 Antibody - middle region : FITC
PAX2 Antibody - middle region : FITC
Referentie P100859_P050-FITC
Formaat : 100ul
Merk : Aviva Systems Biology
Meer informatie aanvragen
Log alstublieft in om deze functie te gebruiken.
Datasheets/Manuals | Printable datasheet for anti-PAX2 (P100859_P050) antibody |
---|
Tested Species Reactivity | Human | ||||||
---|---|---|---|---|---|---|---|
Predicted Species Reactivity | Human, Mouse, Rat, Cow, Dog, Guinea Pig, Rabbit, Sheep, Zebrafish | ||||||
Product Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. | ||||||
Clonality | Polyclonal | ||||||
Host | Rabbit | ||||||
Application | IHC, WB | ||||||
Reconstitution and Storage | For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. | ||||||
Immunogen | The immunogen is a synthetic peptide directed towards the middle region of human PAX2 | ||||||
Purification | Affinity Purified | ||||||
Predicted Homology Based on Immunogen Sequence | Cow: 100%; Dog: 100%; Guinea Pig: 100%; Human: 100%; Mouse: 92%; Rabbit: 100%; Rat: 92%; Sheep: 100%; Zebrafish: 100% | ||||||
Peptide Sequence | Synthetic peptide located within the following region: DPVGSYSINGILGIPRSNGEKRKRDEDVSEGSVPNGDSQSGVDSLRKHLR | ||||||
Concentration | 0.5 mg/ml | ||||||
Blocking Peptide | For anti-PAX2 (P100859_P050) antibody is Catalog # AAP31220 | ||||||
Enhanced Validation |
|
Reference | Bacchetta,J., (2008) Kidney Int. 73 (8), 977-978 |
---|---|
Gene Symbol | PAX2 |
Gene Full Name | Paired box 2 |
Alias Symbols | FSGS7, PAPRS |
NCBI Gene Id | 5076 |
Protein Name | Paired box protein Pax-2 |
Description of Target | PAX2 encodes paired box gene 2, one of many human homologues of the Drosophila melanogaster gene prd. The central feature of this transcription factor gene family is the conserved DNA-binding paired box domain. PAX2 is believed to be a target of transcriptional supression by the tumor supressor gene WT1. Mutations within PAX2 have been shown to result in optic nerve colobomas and renal hypoplasia. PAX2 encodes paired box gene 2, one of many human homologues of the Drosophila melanogaster gene prd. The central feature of this transcription factor gene family is the conserved DNA-binding paired box domain. PAX2 is believed to be a target of transcriptional supression by the tumor supressor gene WT1. Mutations within PAX2 have been shown to result in optic nerve colobomas and renal hypoplasia. Alternative splicing of this gene results in multiple transcript variants. |
Uniprot ID | Q02962 |
Protein Accession # | NP_000269 |
Nucleotide Accession # | NM_000278 |
Protein Size (# AA) | 417 |
Molecular Weight | 45kDa |
Protein Interactions | BBS7; BBS4; BBS2; BBS1; RB1; BRCA1; SFRP2; PAXIP1; WT1; MAPK8IP1; MAPK8; ID2; |
Protein interactions
Name | # of Products |
---|---|
ID2 | 85 |
MAPK8 | 256 |
MAPK8IP1 | 25 |
PAXIP1 | 54 |
RB1 | 474 |
SFRP2 | 12 |
WT1 | 56 |
Biological pathways
Name | # of Products |
---|---|
Anti-apoptosis | 727 |
Axonogenesis | 63 |
Brain morphogenesis | 18 |
Branching involved in ureteric bud morphogenesis | 67 |
Cell fate determination | 24 |
Cellular response to glucose stimulus | 24 |
Cellular response to hydrogen peroxide | 43 |
Cellular response to retinoic acid | 80 |
Cochlea morphogenesis | 27 |
Glial cell differentiation | 10 |
Mesenchymal to epithelial transition involved in metanephros morphogenesis | 19 |
Mesodermal cell fate specification | 6 |
Mesonephros development | 36 |
Metanephric collecting duct development | 16 |
Metanephric distal convoluted tubule development | 9 |
Metanephric mesenchymal cell differentiation | 16 |
Metanephric nephron tubule formation | 16 |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 80 |
Negative regulation of cytolysis | 21 |
Negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 9 |
Negative regulation of reactive oxygen species metabolic process | 6 |
Negative regulation of transcription, DNA-dependent | 660 |
Nephric duct formation | 7 |
Neural tube closure | 43 |
Optic chiasma development | 3 |
Optic cup morphogenesis involved in camera-type eye development | 3 |
Optic nerve structural organization | 3 |
Positive regulation of branching involved in ureteric bud morphogenesis | 57 |
Positive regulation of epithelial cell proliferation | 124 |
Positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 12 |
Positive regulation of metanephric DCT cell differentiation | 9 |
Positive regulation of metanephric glomerulus development | 3 |
Positive regulation of optic nerve formation | 3 |
Positive regulation of transcription from RNA polymerase II promoter | 1210 |
Pronephric field specification | 9 |
Protein kinase B signaling cascade | 24 |
Reactive oxygen species metabolic process | 36 |
Regulation of metanephric nephron tubule epithelial cell differentiation | 12 |
Regulation of metanephros size | 3 |
Retinal pigment epithelium development | 5 |
Stem cell differentiation | 25 |
Transcription from RNA polymerase II promoter | 338 |
Ureter maturation | 3 |
Vestibulocochlear nerve formation | 3 |
Visual perception | 202 |
Biological process
Name | # of Products |
---|---|
Anti-apoptosis | 239 |
Axonogenesis | 78 |
Brain morphogenesis | 12 |
Branching involved in ureteric bud morphogenesis | 47 |
Camera-type eye development | 44 |
Cell fate determination | 15 |
Cellular response to glucose stimulus | 24 |
Cellular response to hydrogen peroxide | 38 |
Cellular response to retinoic acid | 44 |
Cochlea development | 17 |
Cochlea morphogenesis | 24 |
Glial cell differentiation | 24 |
Inner ear morphogenesis | 65 |
Mesenchymal to epithelial transition | 8 |
Mesenchymal to epithelial transition involved in metanephros morphogenesis | 6 |
Mesodermal cell fate specification | 5 |
Mesonephros development | 17 |
Metanephric collecting duct development | 10 |
Metanephric distal convoluted tubule development | 7 |
Metanephric epithelium development | 5 |
Metanephric mesenchymal cell differentiation | 6 |
Metanephric mesenchyme development | 10 |
Metanephric nephron tubule formation | 6 |
Multicellular organismal development | 896 |
Negative regulation of apoptotic process | 356 |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 66 |
Negative regulation of cytolysis | 10 |
Negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 4 |
Negative regulation of programmed cell death | 12 |
Negative regulation of reactive oxygen species metabolic process | 7 |
Negative regulation of transcription, DNA-dependent | 520 |
Nephric duct formation | 3 |
Neural tube closure | 48 |
Optic chiasma development | 2 |
Optic cup morphogenesis involved in camera-type eye development | 3 |
Optic nerve development | 4 |
Optic nerve morphogenesis | 5 |
Optic nerve structural organization | 2 |
Positive regulation of branching involved in ureteric bud morphogenesis | 26 |
Positive regulation of epithelial cell proliferation | 82 |
Positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 9 |
Positive regulation of metanephric DCT cell differentiation | 4 |
Positive regulation of metanephric glomerulus development | 3 |
Positive regulation of optic nerve formation | 2 |
Positive regulation of transcription from RNA polymerase II promoter | 968 |
Positive regulation of transcription, DNA-dependent | 681 |
Pronephric field specification | 2 |
Pronephros development | 8 |
Protein kinase B signaling cascade | 39 |
Reactive oxygen species metabolic process | 23 |
Regulation of metanephric nephron tubule epithelial cell differentiation | 8 |
Regulation of metanephros size | 4 |
Regulation of transcription, DNA-dependent | 1734 |
Retinal pigment epithelium development | 4 |
Stem cell differentiation | 22 |
Transcription from RNA polymerase II promoter | 302 |
Transcription, DNA-dependent | 402 |
Ureter development | 4 |
Ureter maturation | 2 |
Urogenital system development | 20 |
Vestibulocochlear nerve formation | 2 |
Visual perception | 139 |
Cellular components
Name | # of Products |
---|---|
Centriolar satellite | 8 |
Microtubule organizing center | 62 |
Nucleus | 4914 |
Protein complex | 216 |
Protein-DNA complex | 13 |
Protein function
Name | # of Products |
---|---|
Core promoter proximal region sequence-specific DNA binding | 45 |
DNA binding | 3958 |
Superoxide-generating NADPH oxidase activity | 18 |
Transcription regulatory region DNA binding | 657 |
Diseases
Name | # of Products |
---|---|
Disease mutation | 5332 |
- Pax2 Antibody - middle region (ARP31221_P050)Catalog #: ARP31221_P050Species Tested: MouseApplication: WBFormat: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- PAX2 Antibody - middle region (ARP31220_P050)Catalog #: ARP31220_P050Species Tested: HumanApplication: WBFormat: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- PAX2 Antibody - FITC Conjugated (OACA01786)Catalog #: OACA01786Conjugation: FITCApplication: WBFormat: LiquidSize: 100ug
- PAX2 Antibody - Biotin Conjugated (OACA01787)Catalog #: OACA01787Conjugation: BiotinApplication: ELISAFormat: LiquidSize: 100ug
-